Company: BDRX
Filing Date: 2025-05-01
Form Type: DRS
Source: 0001214659-25-006756
Chunk: 20

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-05-01
Form: DRS
Chunk 20
---
 of issuance and ending on the Second Reset Date, and (b) 20% of the most recent NASDAQ
Official Close Price preceding execution of the Underwriting Agreement; and the number of Depositary Shares issuable upon exercise will be increased such that the aggregate exercise price of the Series L Warrants on the issuance
date for the Depositary Sharesunderlying the Series L Warrants then outstanding shall remain
unchanged. Any reduction to the exercise price of the Series L Warrants and resulting increase in the Depositary Sharesunderlying the Series L Warrants will be subject to a floor price. The floor price will be equal to 20% of the most recent
NASDAQ Official Closing Price of the Depositary Sharespreceding execution of the Underwriting
Agreement. If all of the Series L Warrants offered to investors in this offering, including those subject to the underwriter’s overallotment
option for Series L Warrants, are exercised on using the “zero exercise price” option at the floor price of the Series L Warrants,
an aggregate of Depositary Shares would be issued upon such “zero exercise price” option exercise without payment to the Company
of any additional cash.

Furthermore,
the market price of our Depositary Sharescould decline as a result of actual or anticipated
future issuances, including the issuance of shares from Series L Warrant exercises, which will result in substantial dilution to existing
shareholders. The perception of potential dilution from future issuances could depress the market price of our Depositary Shares and could
impair our ability to raise capital through the sale of additional equity securities. We are unable to predict the effect that such sales
may have on the prevailing market price of our Depositary Shares.

You may experience future dilution as a result of future equity offerings.

In order to raise additional
capital, we may in the future offer additional Depositary Shares or other securities convertible into or exchangeable for our Depositary
Shares at prices that may not be the same as the price per share in this offering. We may sell Depositary Shares or other securities in
any other offering at a price per Depositary Share that is less than the price per Depositary Share paid by any investors in this offering,
and investors purchasing shares or other securities in the future could have rights superior to existing Depositary Share holders and
shareholders. The price per Depositary Share at which we sell additional Depositary Shares, or securities convertible or exchangeable
into Depositary Shares, in future transactions may be higher